AddLife Stock

AddLife EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of AddLife (ALIF B.ST) as of Jul 16, 2026 is 16.79. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 20.81 — a change of -19.34% (lower).

EV/EBIT

16.79

YoY

-19.34%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of AddLife is 2026 16.79 . EV/EBIT (Enterprise Value to EBIT) of AddLife was 2025 20.81 . It decreases by -19.34% lower compared to the previous year.

The AddLife EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
39.73 base
Jan 1, 2020
22.96 base
Jan 1, 2021
44.44 base
Jan 1, 2022
15.84 base
Jan 1, 2023
16.56 base
Jan 1, 2024
20.89 base
Jan 1, 2025
19.53 base
Jan 1, 2026 (e)
19.74 base
YEARPRICE-TO-EBIT
2026 est 19.74
2025 19.53
2024 20.89
2023 16.56
2022 15.84
2021 44.44
2020 22.96
2019 39.73
2018 28.49
2017 23.51
2016 27.29
2015 -
Access this data via the Eulerpool API

AddLife Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides AddLife's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates AddLife's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots AddLife's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if AddLife grows earnings faster than its peers.

AddLife Stock analysis

What does AddLife do? AddLife AB is a publicly listed company from Sweden that operates in the medical technology and healthcare industry. The company was founded in 2015 through the merger of several companies. AddLife AB is headquartered in Stockholm and currently employs over 2,000 employees in Sweden, Denmark, Finland, Norway, and Germany. The business model of AddLife AB is based on the acquisition and integration of leading technology companies in the healthcare industry. These companies are integrated into the AddLife Group and supported. Through collaboration within the group, synergies can be leveraged and competitiveness can be increased. AddLife offers its customers a wide range of products and services in various sectors. The company operates in the areas of diagnostics & life science, medical technology, and laboratory products. Diagnostics & life science includes products in the field of in vitro diagnostics, food analysis, nuclear medicine, and animal health. AddLife offers a wide range of products and services that are used in disease research and diagnostics. In the medical technology sector, AddLife AB offers products used by the medical technology industry, hospitals, and healthcare facilities. The product range includes surgical instruments, neurosurgery, orthopedics, and cardiology. AddLife is also involved in the project development of complete solutions for customers in this field. In the laboratory products sector, AddLife AB offers products and services for laboratories and research facilities. The product range includes laboratory equipment, laboratory consumables, and life science products. AddLife also offers services in the maintenance and validation of laboratory equipment. AddLife AB also has its own product brand, Labkotec, which manufactures products for fluid control and environmental and process condition monitoring. Labkotec operates internationally and offers products for various industries, such as the food and beverage industry, energy and environmental industry, steel industry, as well as the chemical and pharmaceutical industry. AddLife is known for its innovative products and solutions and works closely with customers to find individual solutions for their needs. The company sees itself as a provider of solutions and services for the medical industry and aims to improve the health and well-being of people through its products and services. AddLife is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AddLife stock

EV/EBIT (Enterprise Value to EBIT) of AddLife is 16.79 in 2026.

Access this data via the Eulerpool API

Valuation — AddLife

All Key Metrics — AddLife